Bright Minds Biosciences Inc.
NASDAQ:DRUGBiotechnology
+$0.62 today
- Market cap
- $204.78M
- Beta
- -0.11
- P/E (TTM)
- -29.8
- EPS (TTM)
- -$2.87
Volume 0.14M
Average 0.27M
DRUG Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Bright Minds Biosciences Inc.NASDAQ: DRUG
Short-term Investments · Q2 FY2026 · quarter ended Mar 2026
Short-term investments remains negative
Q2 FY2026 short-term investments was CA$172.38K, compared with CA$0 a year earlier.
Context
- Short-term investments amounted to 0.1% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Short-term investments increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
CAD · from the balance sheet
- Latest · FY2025
- 0 CAD
- Year-over-year change
- —
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 0 | — |
| FY2024 | 2024-09-30 | 0 | — |
| FY2023 | 2023-09-30 | 0 | — |
| FY2022 | 2022-09-30 | 0 | — |
| FY2021 | 2021-09-30 | 0 | — |
Short-term Investments vs competitors
How DRUG compares with its peers on the latest reported figures
No competitor Short-term Investments figures are available to compare.
Balance Sheet
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 19.76M | 11.63M | 6.75M | 5.72M | 82.91M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 110.15K | 155.78K | 36.98K | 50.22K | 413.07K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 20.04M | 11.95M | 6.81M | 5.99M | 84.31M |
| Property, Plant & Equipment (Net) | 0 | 138.86K | 66.41K | 117.66K | 111.97K |
| Goodwill | 2K | 0 | 0 | 0 | 0 |
| Intangible Assets | 2 | 0 | 0 | 0 | 0 |
| Long-term Investments | 33.68K | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | (33.68K) | (0) | 0 | 0 | 0 |
| Total Non-current Assets | 2K | 138.86K | 66.41K | 117.66K | 111.97K |
| Total Assets | 20.04M | 12.09M | 6.88M | 6.1M | 84.42M |
| Account Payables | 596.57K | 1.25M | 182.31K | 407.55K | 1.71M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 638.57K | 1.47M | 280.86K | 528.68K | 2.34M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 71.98K | 0 | 39.58K | 41.25K |
| Total Liabilities | 638.57K | 1.54M | 280.86K | 568.26K | 2.38M |
| Common Stock | 27.08M | 32.24M | 33.91M | 35.42M | 123.25M |
| Retained Earnings | (9.21M) | (24.17M) | (31.55M) | (34.35M) | (46.58M) |
| Accumulated OCI | 1.57M | 2.48M | 3.4M | 4.01M | 5.37M |
| Other Stockholders Equity | (33.68K) | 0 | 831.83K | 455.57K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 19.4M | 10.54M | 6.6M | 5.54M | 82.04M |
| Total Debt | 0 | 139.91K | 73.55K | 118.96K | 125.78K |
| Net Debt | (19.76M) | (11.49M) | (6.67M) | (5.6M) | (82.78M) |
Bright Minds Biosciences Inc.
NASDAQ:DRUG
Intrinsic Alpha fair value
Locked
Current Price
$20.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.